Skip to main content
. Author manuscript; available in PMC: 2015 May 24.
Published in final edited form as: Neurosurgery. 2013 Jun;72(6):960–970. doi: 10.1227/NEU.0b013e31828cf619

Table 2.

Prior immunosuppressive therapy and EBV/CMV status of 10 patients with Primary CNS Post-Transplant Lymphoproliferative Disorder.

N
Prior rejection episodes of organ allograft 9 (90%)
 Steroid-refractory 2 (20%)

Prior exposure to immunosuppressive agents for treatment of organ rejection:
 OKT3 0
 ATG 4

Immunosuppressive agents at time of PTLD diagnosis:
 Cyclosporine 2
 Tacrolimus 3
 Mycophenolate 10
 Prednisone 10

One patient had received ATG prophylactically as pre-transplant conditioning regimen.

Abbreviations: OKT3 = murine monoclonal antibody targeting CD3. ATG = anti-thymocyte globulin.